CHEYENNE, Wyo.--(BUSINESS WIRE)--MedX Holdings, Inc. (OTC Pink: MEDH) (the Company) is pleased to announce the acquisition of BioHydro LLC.
BioHydro is the servicing arm that will manage the development, infrastructure, and construction of a processing facility in Arizona’s saturated zone, for the purpose of targeting approximately 2 trillion gallons of pharmaceutical grade water on 163 acre parcels. This particular grade of water has already been tested for characteristics; such as, purity and high Ph factors, which makes it a highly desirable commodity for pharmaceutical and biological applications. Industry leaders retail their PHarma H2O in excess of $60.00 per gallon, and we are currently evaluating a per gallon price for our entry into this market.
MedX Holdings and BioHydro will be managed by an expert with over 30 years in complex real estate transactions. These interior corporate changes will be transitioned seamlessly over the next few weeks and we encourage shareholders to follow our Twitter account for updates.
The BioHydro opportunity presents a viable avenue for exponential revenue generation; which has the company re-evaluating its current residential real estate and construction subsidiaries for possible unwinding to fully focus on its entry as a service provider to the pharmaceutical industry.
Stated CEO, Mark Miller: “In the coming weeks the company will be doing a series of audio interviews that will explain in greater detail the new industry sector and the opportunity for significant revenue generation. We will also be discussing the corporate changes, and why the company felt it was important to make this move.”
Follow us on Twitter @MedX_Holdings
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements.